Tilray Brands, Inc. (NASDAQ: TLRY) is a prominent player in the healthcare sector, specifically within the drug manufacturing industry focusing on specialty and generic products. As a Canadian company, Tilray has established a global footprint, engaging in the cultivation, processing, and distribution of medical cannabis products across Canada, the United States, Europe, the Middle East, Africa, and beyond. Its diverse product portfolio includes medical and adult-use cannabis, pharmaceutical and wellness products, beverages, and hemp-based foods.

Currently, Tilray’s stock is priced at $7.89, with a subtle price change of 0.31 (0.04%). Despite its broad product offerings and international reach, Tilray’s financials present a…